Advertisement

Topics

Denovo Biolabels Company Profile

16:09 EST 21st November 2017 | BioPortfolio

Denovo Biolabels GmbHspecializes in the

development of fluorescent

markers for bioanalytical

applications.



The R&D team combines

a profound knowledge in the

organic synthesis of

fluorescent dyes with many

years of practical experience

in life sciences

Location

Mendelstrasse 7
Munster
D - 48149
Germany

Contact

Email: info@biolabels.com


News Articles [3 Associated News Articles listed on BioPortfolio]

Denovo Biomarkers: Robert Little. Providing a novel biomarker solution to personalize drug development

Robert Little, the Chief Business Officer of Denovo Biomarkers reveals to Fintan Walton the use of its industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospect...

Denovo Approved to Start US-China Phase III Trials of Lymphoma Drug

Denovo Biopharma, a San Diego-Beijing company, announced approval from the FDA to conduct a US Phase III trial of its lead drug in patients with Diffuse Large B Cell Lymphoma (DLBCL). The same trial (...

Week in Review: China Resources Pharma Files for $369 Million China Life Science Investment Fund

Deals and Financings China Resources Pharma announced plans to raise $368.5 million for a China life science investment fund; Chi-Med (Hutchison China MediTech) completed a $301 million secondary of...

Drugs and Medications [0 Results]

None

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Dual-mode blue emission, enhanced up-conversion luminescence and paramagnetic properties of ytterbium and thulium-doped Ba2GdF7 multifunctional nanophosphors.

A series of Ba2GdF7:Yb(3+), Tm(3+) nanophosphors (NPs) with dual-mode (down-conversion (DC) and upconversion (UC)) luminescence were successfully prepared by hydrothermal method at 180°C. The NPs hav...

Clinical Trials [6 Associated Clinical Trials listed on BioPortfolio]

Post Market Study of DeNovo NT, Natural Tissue Graft

The purpose of this post market study is to evaluate surgical implantation technique and the quality of repair of the cartilage defect with particulated juvenile cartilage in the human kne...

eTryton Left Main Registry of the Tryton Side Branch Stent® Treatment of Denovo CAD in Both LM and Circumflex Coronary Arteries

The objective of this study is to demonstrate the clinical performance of the Tryton Side Branch Stent used in conjunction with a commercially available Drug Eluting Stent (DES) to treat d...

Human Autograft Mesenchymal Stem Cell Mediated Stabilization of The Degenerative Lumbar Spine

Investigate the potential of tissue grafting that includes human mesenchymal stem cells in the repair and potential stabilization of the degenerative Lumbar disk and facet joint denovo and...

Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD)

Rituximab is an attractive agent to bring to the upfront treatment of cGVHD due to its favorable toxicity profile, its proven efficacy in the treatment of steroid-refractory chronic GVHD, ...

Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-Dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-Term Steroids

All patients of the core study who are interested of being treated with EC-MPS will be included in an open-label extension study to collect further information on the long-term safety, tol...

Companies [4 Associated Companies listed on BioPortfolio]

Denovo Biolabels GmbH

Denovo Biolabels GmbHspecializes in the development of fluorescent markers for bioanalytical application

Denovo Biolabels

Denovo Biolabels GmbHspecializes in the development of fluorescentmarkers for bioanalytical applications. The R&D team combinesa profound knowledge in theorganic synthesis of fluorescent dyes with ma...

Benvenue Medical, Inc.

Founded in 2004, Benvenue Medical, Inc. provides next generation minimally invasive systems for spine repair that combine expandable implants with novel delivery instruments to pr...

DNA 2.0

Improvements in DNA sequencing and information technologies are driving an exponential increase in the amount of genomic data available. Despite the massive amounts of resources dedicated to accumulat...

More Information about "Denovo Biolabels" on BioPortfolio

We have published hundreds of Denovo Biolabels news stories on BioPortfolio along with dozens of Denovo Biolabels Clinical Trials and PubMed Articles about Denovo Biolabels for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Denovo Biolabels Companies in our database. You can also find out about relevant Denovo Biolabels Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record